$VERUSep 2, 2026, 12:30 PMAI processed

VERU CEO to speak at Cantor Healthcare conference; PLATEAU Phase 2b fully enrolled

AI Summary

Veru said CEO Mitchell Steiner will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Sept. 9 (webcast available). The company also reported the PLATEAU Phase 2b trial of enobosarm plus semaglutide is fully enrolled at 239 patients (vs a 200 patient target), with a DXA-based interim analysis due in Q1 2027 and final topline data expected in Q4 2027.

Positives

PLATEAU Phase 2b trial exceeded enrollment target with 239 patients versus a 200 patient target
Interim DXA analysis expected in Q1 2027 and final topline data expected in Q4 2027

Negatives

Final topline data not expected until Q4 2027, leaving a long wait for main efficacy readout
Company is prioritizing cash toward enobosarm development; advancement of sabizabulin depends on securing additional funding
Supply agreement with Novo Nordisk contains a 60-day convenience termination provision

Company Info

Company:: Veru Inc
Exchange:: Nasdaq
Industry:: Pharmaceuticals
Country:: US
Website:: https://verupharma.com
Market cap:: 37.40M
Shares outstanding:: 16.05M

Now available

TradersLink Beta App

Free beta access for all TradersLink Discord members(free and premium members)

Daily Trade Tracker

Enter the executions you took each day and TradersLink builds the trades for you. Review them by ticker with trade replay charts, then add trade notes, tags, and rules. Finish the day with what went well, what to work on, and your main focus for next time.

Trade Analyzer

Analyze every trade—not just your totals. Review detailed entry, exit, and complete-trade analysis, then use long-term results to study your execution habits over time. See missed profit opportunities, exits that may have happened too early, and trades that were green before they finished red. Candle-pattern data helps you study the conditions around your entries and exits.

Smart Rules

Use preset trading rules that TradersLink can track from your recorded trades. Review when a rule may have been broken, see your results over time, and create custom rules for your own process.

Press Release Alerts

Get press-release alerts inside your dashboard, including alerts when a stock is halted, so important news is visible while you track your trades.

Trade Explorer

Open a completed trade and go deeper. Review its executions, result, notes, tags, rules, and analysis in one place.

Analytics

Understand your trading history from more than one angle. Explore results by ticker, time of day, holding time, setups, and other patterns supported by your recorded trades.